ABL Diagnostics S.A. Logo

ABL Diagnostics S.A. (9BK0)

FSX

Currency in EUR
2.00
+0.06 (+3.09%)

Closed

Oct 9, 2026

Day's Range

1.88
2.00

52 wk Range

1.85
4.32

Overview - 9BK0 - ABL Diagnostics S.A.

Key Statistics

Valuation

Enterprise Value

32.02M

P/E (Trailing)

‪16.00‬

Price / Sales (TTM)

‪2.93‬

Price / Book

‪4.04‬

EV / EBITDA

‪31.33‬

Profitability

Profit Margin

‪18.77%‬

Operating Margin

‪20.59%‬

Return on Assets

‪7.61%‬

Return on Equity

‪12.92%‬

Ownership

Shares Outstanding

16.06M

Float

990.03K

Held by Insiders

‪93.57%‬

Held by Institutions

‪0.00%‬

Price stats

Beta

‪-0.56‬

50-Day Avg

‪2.23‬

200-Day Avg

‪2.62‬

Dividends

Payout Ratio

‪89.43%‬

Frequency

Annual

News Teaser - 9BK0 - ABL Diagnostics S.A.

News & Analysis

View all news

Market Cap - 9BK0 - ABL Diagnostics S.A.

Peers - 9BK0 - ABL Diagnostics S.A.

Peer Comparison

Compared with companies in Health Information Services listed on FSX.

Profile Summary - 9BK0 - ABL Diagnostics S.A.

About

ABL Diagnostics S.A. is a biotechnology company specializing in innovative molecular biology tests and comprehensive solutions for microbiology diagnostics. It develops and markets proprietary assays including DeepChek® for genotyping through DNA sequencing and UltraGene® for molecular polymerase chain reaction (PCR)…

SectorHealthcare
IndustryHealth Information Services
Employees22
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.